US Patent Issued to Prothera Biologics on April 29 for "Methods for treating pulmonary disease using inter-alpha inhibitor proteins" (Rhode Island Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,471, issued on April 29, was assigned to Prothera Biologics Inc. (Providence, R.I.).

"Methods for treating pulmonary disease using inter-alpha inhibitor proteins" was invented by Yow-Pin Lim (Providence, R.I.), Denice Spero (Providence, R.I.) and Richard Andrews (Providence, R.I.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention features methods for treating or preventing pulmonary diseases, including acute respiratory distress syndrome (ARDS) and pneumonia, in a subject in need thereof that involve administering to the subject inter-alpha inhibitor proteins (IAlphaIps), including, e.g., inter-alpha inhibitor (IAlphaI) and/or pre-alpha inh...